Ikarian Capital, LLC Alector, Inc. Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$21.65 - $39.49 $14.6 Million - $26.6 Million	-674,723 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $6.47 Million - $9.38 Million	417,223 Added 162.03%	674,723 $14.1 Million
Q1 2021 May 17, 2021	BUY	$14.84 - $22.23 $2.97 Million - $4.45 Million	200,000 Added 347.83%	257,500 $5.19 Million
Q4 2020 Feb 12, 2021	BUY	$9.4 - $16.7 $537,482 - $954,889	57,179 Added 17812.77%	57,500 $870,000
Q3 2020 Nov 16, 2020	BUY	$10.54 - $24.96 $3,383 - $8,012	321 New	321 $3,000

167

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $336M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.